FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer

Veridex announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic colorectal cancer.
Johnson & Johnson